SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Astronomers detect black hole blasting winds at incredible speeds - 2Iran plans new restrictions in overhaul of Strait of Hormuz rules
- 3Timothy Busfield turns himself in to face child sexual abuse charges in New Mexico
- 4Fundamental Home Items Each Animal person Needs
- 5Police break up illegal chicken slaughter in Germany
- Meet the Artemis crew in NASA's first astronaut mission to the moon in more than a half-century
- Artemis II crew take new photo of far side of the moon
- Step into Nature: A Survey of \Handling Trails with Solace\ Climbing Shoes
- A24's 'Backrooms' trailer shows endless fluorescent-lit spaces and terrifying mannequins melting into the floor
- Astronomers discover never-before-seen celestial object: "Cloud 9"
- Scientists find twisting magnetic waves on the sun. Could this help solve a huge solar mystery?
- From Sea shores to Urban areas: Astonishing Worldwide Travel Objections
- Ukraine's new defense minister just outlined how dire its troop shortage has become
- Teen drug use remains low, but survey finds small rise in heroin and cocaine use
